Effect of sequential introduction of 13-valent pneumococcal conjugate vaccine (PCV) after 7-valent pneumococcal conjugate vaccine in Southern Israel children with otitis media

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
Indications Otitis media
Focus Therapeutic Use

28 Jan 2021 Results of nested case-control study within an ongoing study assessing effectiveness of PCV7 and PCV13 against complex OM caused by the targeted serotypes, using contemporary subjects with rotavirus-negative gastroenteritis as controls, published in the Clinical Infectious Diseases
01 Oct 2020 Results published in the Journal of Antimicrobial Chemotherapy
30 Dec 2015 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com